NO930359L - Immunregulatoriske og neuroregulatoriske pentapeptider - Google Patents

Immunregulatoriske og neuroregulatoriske pentapeptider

Info

Publication number
NO930359L
NO930359L NO93930359A NO930359A NO930359L NO 930359 L NO930359 L NO 930359L NO 93930359 A NO93930359 A NO 93930359A NO 930359 A NO930359 A NO 930359A NO 930359 L NO930359 L NO 930359L
Authority
NO
Norway
Prior art keywords
pro
carbon atoms
pentapeptides
group
dehydro
Prior art date
Application number
NO93930359A
Other languages
English (en)
Norwegian (no)
Other versions
NO930359D0 (no
Inventor
Gideon Goldstein
Tapan Audhya
George Heavner
Mohmed K Anwer
Original Assignee
Immunobiology Res Inst Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunobiology Res Inst Inc filed Critical Immunobiology Res Inst Inc
Publication of NO930359D0 publication Critical patent/NO930359D0/no
Publication of NO930359L publication Critical patent/NO930359L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/66—Thymopoietins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO93930359A 1991-06-03 1993-02-02 Immunregulatoriske og neuroregulatoriske pentapeptider NO930359L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/708,035 US5215964A (en) 1991-06-03 1991-06-03 Peptides useful in regulating the immune and nervous systems
PCT/US1992/004484 WO1992021366A1 (en) 1991-06-03 1992-05-28 Immunoregulatory and neuroregulatory pentapeptides

Publications (2)

Publication Number Publication Date
NO930359D0 NO930359D0 (no) 1993-02-02
NO930359L true NO930359L (no) 1993-03-18

Family

ID=24844123

Family Applications (1)

Application Number Title Priority Date Filing Date
NO93930359A NO930359L (no) 1991-06-03 1993-02-02 Immunregulatoriske og neuroregulatoriske pentapeptider

Country Status (20)

Country Link
US (1) US5215964A (en])
EP (1) EP0517464A1 (en])
JP (1) JPH06501955A (en])
CN (1) CN1068334A (en])
AU (1) AU653838B2 (en])
BR (1) BR9205281A (en])
CA (1) CA2088664A1 (en])
CZ (1) CZ7793A3 (en])
FI (1) FI930342A0 (en])
HU (1) HUT63856A (en])
IE (1) IE921781A1 (en])
IL (1) IL102065A0 (en])
MX (1) MX9202643A (en])
NO (1) NO930359L (en])
NZ (1) NZ242993A (en])
SK (1) SK4093A3 (en])
TW (1) TW222281B (en])
WO (1) WO1992021366A1 (en])
YU (1) YU58392A (en])
ZA (1) ZA924023B (en])

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995003067A1 (en) * 1993-07-21 1995-02-02 Khavinson Vladimir Khatskelevi Pharmaceutical with immunomodulating activity
GB9425582D0 (en) * 1994-12-19 1995-02-15 Iaf Biochem Int Peptides having immunomodulatory activity
AU4222200A (en) * 1999-04-15 2000-11-02 Thymon L.L.C. Nonextractive method of assaying thymopoietin
CN104311640B (zh) * 2014-11-27 2017-08-25 上海弭阳生物技术有限公司 一种免疫修复15肽、其制备方法及其应用
WO2017133175A1 (en) * 2016-02-04 2017-08-10 Nanjing Legend Biotech Co., Ltd. Engineered mammalian cells for cancer therapy

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE263994C (en]) *
DE2639941C2 (de) * 1976-09-04 1984-10-04 Hoechst Ag, 6230 Frankfurt Verfahren zur Herstellung von Phosphin
US4397842A (en) * 1980-03-13 1983-08-09 Ortho Pharmaceutical Corporation Peptides having thymopoietin-like activity
US4505853A (en) * 1983-11-18 1985-03-19 Ortho Pharmaceutical Corporation Enzyme-resistant immunomodulatory peptides
US4629723A (en) * 1984-06-27 1986-12-16 Ortho Pharmaceutical Corporation Potent thymopentin analogs
DD263994A1 (de) * 1987-07-09 1989-01-18 Univ Halle Wittenberg Verfahren zur herstellung von oligodesoxyribonucleotiden zur splenopentinexpression
DD296084A5 (de) * 1989-07-27 1991-11-21 Adw Verfahren zur herstellung von humanen spleninderivaten
EP0563212A1 (en) * 1990-11-23 1993-10-06 Immunodynamics, Inc. Synthetic immunoactive peptides having immunomodulating and therapeutic activities

Also Published As

Publication number Publication date
NO930359D0 (no) 1993-02-02
BR9205281A (pt) 1993-07-27
CA2088664A1 (en) 1992-12-04
AU653838B2 (en) 1994-10-13
MX9202643A (es) 1994-08-31
WO1992021366A1 (en) 1992-12-10
IL102065A0 (en) 1993-01-14
SK4093A3 (en) 1993-09-09
AU2012592A (en) 1993-01-08
IE921781A1 (en) 1992-12-16
CZ7793A3 (en) 1993-12-15
JPH06501955A (ja) 1994-03-03
ZA924023B (en) 1993-02-24
FI930342A7 (fi) 1993-01-27
YU58392A (sh) 1995-03-27
FI930342L (fi) 1993-01-27
HU9300278D0 (en) 1993-04-28
NZ242993A (en) 1995-09-26
CN1068334A (zh) 1993-01-27
HUT63856A (en) 1993-10-28
EP0517464A1 (en) 1992-12-09
TW222281B (en]) 1994-04-11
FI930342A0 (fi) 1993-01-27
US5215964A (en) 1993-06-01

Similar Documents

Publication Publication Date Title
HUT73417A (en) Enniatines and enniatine derivatives used to control endoparasites
SE9404115D0 (sv) Salter av peptider med karboxiterminerade polyestrar
IL105727A (en) 7-(2-mercapto-acetamido)-octahydro-6-oxopyrido[2,1-a][2]-benzazepine derivatives analogs thereof their preparation and pharmaceutical enkephalinase-inhibiting compositions containing them
EP0564739A3 (en])
ES2040373T3 (es) Esteroides puenteados en 19,11beta, su preparacion y preparados farmaceuticos que contienen estos compuestos.
IL75637A0 (en) Thymopentin analogs and pharmaceutical compositions containing them
IL70077A0 (en) Beta-carboline derivatives and pharmaceutical compositions containing the same
ZA939578B (en) Vinylene azaindole derivatives and process for their preparation
ATE177757T1 (de) Verbesserte immunogene zusammensetzung gegen mensliches gastrin 17
DE69021176D1 (de) Polypeptid und Verfahren zu dessen Herstellung.
CO4790174A1 (es) Analogos del peptido lh-rh, sus usos y composiciones farmaceuticas que los contienen
ES478803A1 (es) Un procedimiento para la preparacion de derivados de acila- dos de muramil peptidos.
ES2074492T3 (es) Derivados de acidos biliares, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
MY100883A (en) The use of salicylic acid esters as perfumes, perfume compositions containing them and new salicylic esters.
NO930359L (no) Immunregulatoriske og neuroregulatoriske pentapeptider
GB1297398A (en])
ES2060123T3 (es) Aminoacidos protegidos y procedimientos para su fabricacion.
ES433860A1 (es) Procedimiento de preparacion de derivados del acido ciclo- pentano-carboxilico.
GR3002558T3 (en) Synergistinic derivatives, their preparation and pharmaceutical compositions containing them
ES471672A1 (es) Un procedimiento para la preparacion de un peptido
NO960710L (no) Nye tripeptider nyttige i immun- og CNS-terapi
ES8304571A1 (es) "procedimiento para la preparacion de nuevas 1,4,9,10-tetrahidro-pirazolo (4,3-e)pirido (3,2-b) (1,4)diazepin-10-onas".
ES8307224A1 (es) Un metodo para preparar derivados de pirazolina.
EP0717618A4 (en) STABILIZED FORMULATION FOR TABLETS
ES2155546T3 (es) Bencenosulfonil-ureas y -tioureas sustituidas, procedimiento para su preparacion y el uso de preparaciones farmaceuticas basadas en estos compuestos, asi como medicamentos que los contienen.